Cephalexin Dosing for Adult UTI
For uncomplicated cystitis in adults, cephalexin 500 mg twice daily for 7 days is the recommended dosing regimen, though it should be considered a second-line agent when preferred options like nitrofurantoin or fosfomycin cannot be used. 1
Standard Dosing
The FDA-approved dosing for uncomplicated cystitis is:
- 500 mg every 12 hours (twice daily) for 7-14 days 1
- Alternative: 250 mg every 6 hours (four times daily), though this is less convenient
Recent evidence supports that twice-daily dosing (500 mg BID) is equally effective as four-times-daily dosing for uncomplicated UTI, with no difference in treatment failure rates (12.7% vs 17%, P=0.343) and potentially better adherence 2. This makes BID dosing the preferred practical approach.
Duration of Treatment
The 2024 guideline notes insufficient evidence to provide a clear recommendation for β-lactam duration in cystitis 4, but the FDA label and clinical practice support 7-14 days 1.
Important Caveats
Position in Treatment Algorithm
Cephalexin is NOT a first-line agent for uncomplicated cystitis. The 2024 guideline clearly states that nitrofurantoin is the reasonable drug of choice for uncomplicated cystitis, as it spares more systemically active agents 4. The 2011 IDSA/ESMID guidelines classify β-lactams like cephalexin as agents to use "when other recommended agents cannot be used" due to inferior efficacy and more adverse effects compared to other UTI antimicrobials 3.
Efficacy Concerns
β-lactams have documented limitations:
- Lower cure rates compared to fluoroquinolones and TMP-SMX
- Higher adverse event rates
- Should be used "with caution" for uncomplicated cystitis 3
- Recent data shows cefdinir (another oral cephalosporin) has nearly twice the failure rate of cephalexin, highlighting variability among β-lactams 5
When to Use Cephalexin
Consider cephalexin when:
- Nitrofurantoin, fosfomycin, or pivmecillinam are contraindicated or unavailable
- TMP-SMX resistance exceeds 20% locally AND patient has no recent fluoroquinolone use
- Fluoroquinolones need to be reserved for more serious infections
- Patient has documented susceptibility to cephalexin
Renal Dosing Adjustments
Critical consideration: While the FDA label doesn't specify dose adjustments for mild-moderate renal impairment, cephalexin achieves adequate urinary concentrations even in patients with impaired renal function 6. However:
- CrCl >50 mL/min: Standard dosing (500 mg BID)
- CrCl 10-50 mL/min: Urinary concentrations remain adequate for most UTI pathogens 6, 7, but consider extending interval or reducing dose based on severity
- CrCl <10 mL/min or anephric patients: Significantly prolonged serum concentrations occur; reduce dose substantially (e.g., 250-500 mg every 12-24 hours) 6
- Hemodialysis: Removes approximately 58% of cephalexin over 6 hours; dose after dialysis 6
Important: Nitrofurantoin and sulfamethoxazole have inadequate urine concentrations when CrCl <50 mL/min 8, making cephalexin a more reasonable choice in this population despite being second-line in normal renal function.
Practical Algorithm
- Confirm diagnosis: Uncomplicated cystitis in non-pregnant adult
- Check local resistance patterns and patient risk factors
- First-line options (in order): Nitrofurantoin 5 days → Fosfomycin single dose → Pivmecillinam 3 days (if available)
- If first-line agents contraindicated: Cephalexin 500 mg BID for 7 days
- Obtain culture if using cephalexin to confirm susceptibility
- Adjust for renal function if CrCl <50 mL/min
Monitoring
- If symptoms persist beyond 48-72 hours, consider treatment failure
- Treatment failure with cephalexin may indicate cephalosporin-resistant organisms 5
- Repeat culture if treatment fails to guide alternative therapy
The key message: Cephalexin works for UTI but is not optimal first-line therapy due to inferior efficacy compared to nitrofurantoin and other preferred agents 4, 3. Use it when better options are unavailable, and always consider local resistance patterns and patient-specific factors.